Back to Results
First PageMeta Content
Organic chemistry / Eflornithine / Organofluorides / Amines / Ketones / African trypanosomiasis / Hair removal / Methadone / Medicine / Chemistry / Antiprotozoal agents


Bristol-Myers Squibb Labeling VANIQA - July 27, 2000 Rx only
Add to Reading List

Document Date: 2009-03-31 16:58:23


Open Document

File Size: 133,22 KB

Share Result on Facebook

City

Buffalo / /

Company

Bristol-Myers Squibb Company Westwood-Squibb Colton Holdings / Bristol-Myers Squibb Company / Westwood-Squibb Colton Holdings / Ames / Bristol-Myers Squibb / /

Country

United States / /

Event

FDA Phase / /

Facility

STORAGE Store / /

IndustryTerm

applied drug products / body systems / licensed healthcare professional / healthcare professional / mineral oil / /

MedicalCondition

fetal resorptions / headache / cheilitis / seizures / leukopenia / thrombocytopenia / herpes / numbness / spontaneous abortions / birth defect / stomach upset / hypersensitivity / Erythema (redness) Tingling Skin Dyspepsia Skin Irritation Rash Alopecia Dizziness Folliculitis Hair Ingrown Facial edema Anorexia Nausea Asthenia Vertigo VANIQA / hearing impairment / contact irritation / Significant dermal irritation / severe inflammatory acne / photosensitization / Carcinogenesis / Folliculitis / Trypanosoma brucei gambiense infection / skin irritation / rosacea / photocontact irritation / skin tumors / irritation / contact dermatitis / dizziness / rash / anemia / Syndrome / African sleeping sickness / /

MedicalTreatment

hair removal / /

/

Position

PRECAUTIONS General For external use only / pharmacist / Physician / /

Product

VANIQA / /

ProgrammingLanguage

C / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag